ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,107.60
0.99%
Dow Jones
39,721.36
1.09%
Brent Oil
85.385
0.39%
Bitcoin
57,823.46
0.12%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
10/27/20217:53AMDow Jones NewsGlaxoSmithKline 3Q Net Profit Fell Slightly; Raises 2021 Adjusted EPS ViewNYSE:GSKGSK plc
10/27/20216:48AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/26/20218:47AMPR Newswire (US)Theraflu Launches the Rest & Recover Fund to Help More Americans Take a Sick Day When NeededNYSE:GSKGSK plc
10/26/20218:32AMGlobeNewswire Inc.Berkeley Lights Announces GSK Acquires Third Beacon® Optofluidic System to Expand Antibody Therapeutics DevelopmentNYSE:GSKGSK plc
10/14/202112:38PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/14/20218:30AMTipRanksGlaxoSmithKline Gains, Consumer Unit Sale May Be AheadNYSE:GSKGSK plc
10/13/20219:29AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/12/202112:02PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/12/202111:57AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/12/202111:28AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/12/20217:18AMDow Jones NewsGlaxoSmithKline Fields Interest in GBP40 Billion Consumer Unit -BloombergNYSE:GSKGSK plc
10/11/20215:34AMDow Jones NewsArecor Therapeutics Shares Jump as Vaccine Patent Is Upheld by European Patent OfficeNYSE:GSKGSK plc
10/01/20217:28AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/30/202111:31AMDow Jones NewsCorrection to Merck, GlaxoSmithKline ArticleNYSE:GSKGSK plc
09/30/202110:57AMDow Jones NewsMerck KGaA, GlaxoSmithKline Terminate Agreement on Cancer Drug DevelopmentNYSE:GSKGSK plc
09/28/20218:52AMPR Newswire (US)Sensodyne® Repair and Protect with Deep Repair is Proud to Deliver a Minty & Whitening Toothpaste, Just in Time for National Coffee DayNYSE:GSKGSK plc
09/28/20218:12AMDow Jones NewsViiV Gets FDA Priority Review for Cabotegravir Long-Acting for HIV PreventionNYSE:GSKGSK plc
09/24/20212:03PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/23/20216:31AMDow Jones NewsActivist Bluebell Capital Takes Small Stake in GSK to Push for Board Change -FTNYSE:GSKGSK plc
09/22/202112:09PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/20/202110:15AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/13/20211:49PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/09/202112:36PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/07/20211:38PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/03/20217:19AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/01/20219:12AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
08/31/20218:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
08/31/20212:50AMDow Jones NewsGlaxoSmithKline, SK Bioscience Begin Phase 3 Trial of Covid-19 VaccineNYSE:GSKGSK plc
08/25/20219:44AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
08/23/202112:55PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
NASDAQ
FCEL
FuelCell Energy
USOTC
RONN
Ronn Motor (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RXMD
Progressive Care (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
AXXA
Exxe (PK)
AMEX
SPY
SPDR S&P 500
NASDAQ
AMRN
Amarin
USOTC
RNVA
Rennova Health (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved